Celltrion is expanding its market presence in Peru, a major Latin American country, by winning a series of successful public tenders.First of all, Truxima (rituximab) 500 mg won a tender held by the National Health Ministry of Peru (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud
On Aug. 31, Celltrion announced it has completed the product approval application for its autoimmune disease therapeutic “CT-P43,” a biosimilar of STELARA (ustekinumab), to Australia’s Therapeutic Goods Administration (TGA).Celltrion applied for CT-P43’s product approval in Australia for all indicat
GC Wellbeing announced on July 15 that it has signed a technology licensing-out contract with Japan’s Healthy Navi for its functional raw material Green Cera-F (lonicera japonica flower extract or honeysuckle extract). Healthy Navi is a company that develops and distributes functional and general fo
AIA Life announced on Sept. 10 the launch of its innovative new ‘(Non-par) AIA Vitality Reliable Wellness Cancer Plan (Renewal)’, another addition to the Vitality Discounted Integrated Product portfolio.The new plan aims to help customers live healthier, longer and better lives by providing health m
Ildong Pharmaceutical has acquired a patent on a composition that can improve dyslipidemia by utilizing live and heat-killed probiotic strains.While conventional medicines treat hyperlipidemia by inhibiting cholesterol synthesis in the body, the company has developed a composition that can discharge
Jeil Pharmaceutical is stepping up efforts to develop new medicines. Onconic Therapeutics, a subsidiary specializing in new drug development, raised about 27.5 billion won through a capital increase in January and February to finance clinical trials of its new drug candidates.Jeil Pharmaceutical fou
Boryung Pharmaceutical has signed a contract with SN BioScience for exclusive sale in Korea of the world's first nano-micelle anticancer drug SN-101 (component name: Nanocomposite SN-38).Through this contract, Boryung Pharmaceutical will hold exclusive sales rights in Korea for 10 years after th
Hutom, a Korean medical software startup, announced on Nov. 30 that it will launch the world’s first artificial intelligence-empowered recording equipment for minimally invasive surgery in the first quarter of next year.The company’s equipment, dubbed AI-Empowered ViHub, is used for minimally invasi
Daewoong Pharmaceutical Co. announced on June 19 that clinical results on gallstone prevention effects of its liver drug "Ursa" have been published in the SCI-level international journal JAMA Surgery.Published since 1920, JAMA Surgery is the official journal of the Association of VA Surgeons, the Pa
JW Pharmaceutical announced on May 12 that the results of phase 1a clinical trials (single dose) on CWP291, a candidate material for acute myeloid leukemia (AML), has been published in the online edition of Blood Advances, a journal published by the American Society of Hematology (ASH).CWP291 is a t
uLikeKorea announced on Feb. 27 that it has successfully developed the world’s first micro-bio capsule to manage and detect calve-related diseases. The bio micro-capsule is 400 percent smaller than the original version of the calf capsule developed earlier by uLikeKorea.uLikeKorea is already well-kn
SK Chemicals announced on Dec. 12 that it has received final approval from the U.S. Food and Drug Administration (FDA) to sell its dementia treatment patch “SID710” (ingredient name is Rivastigmine) in the U.S. market. It is the first time for a dementia treatment patch developed by a Korean pharmac
SK Chemicals announced on Nov. 27 that the U.S. Food and Drug Administration (FDA) has given the nod to its dementia treatment patch SID710 (element name: Rivastigmine). SID710 has become the first dementia treatment patch developed in Korea to receive FDA approval.SK Chemicals developed SID710 in 2
CJ Healthcare announced on Sept. 18 that it has signed an agreement with Indonesian drug company Kalbe Farma to supply K-CAB (the ingredient name Tegoprazan), a new drug for gastroesophageal reflux disease (GERD).Under the agreement, CJ Healthcare will supply K-CAB to Kalbe Farma for five years afte
As Samsung Electronics's earnings shock shows that the memory semiconductor business has shifted into a downturn, semiconductor industry experts forecast that Chinese memory makers will slow down their aggressive investment drive. Some expect that China's memory mass-production will be postp
K-water, a state-run corporation specializing in water resources development, has won a hydroelectric power project worth US$211 million in the Solomon Islands.The Korean corporation announced on Dec. 5 that it would sign a contract on the Tina River hydroelectric power generation project with the S
A string of new drug candidate materials and biobetters (new drugs for bio-pharmaceuticals) from Korean pharmaceutical and biotechnology companies have been granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA). Domestic pharmaceutical and biotech companies are expecte
Samsung Bioepis and Celltrion are competing to become the first Korean company to develop a biosimilar to “Avastin,” a blockbustger drug for colorectal cancer developed by global pharmaceutical company Roche.The two companies previously competed over the development of a biosimilar to “Herceptin,” a
Celltrion Healthcare announced on August 23 that it began sales of Herzuma, Celltrion's biosimilar (a biologic medical product that is almost an identical copy of an original product) for the treatment of breast cancer and stomach cancer in Japan.Celltrion Healthcare is a subsidiary in charge of
A shocking incidence happened to a South Korean consumer who was eating Haagen-Dazs ice cream on July 9.Around midnight on the day, a tip was posted on a Korean internet community site saying a 3 cm caterpillar was found in Haagen-Dazs strawberry ice cream. The informant said, “I heard a crunchy sou